Skip to main content

Advertisement

Log in

Radioiodine versus radiofrequency ablation to treat autonomously functioning thyroid nodules: a systematic review and comparative meta-analysis

  • Original Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

An Editorial to this article was published on 15 March 2024

Abstract

Purpose

Radioiodine (RAI) is a well-established first-line therapy for autonomously functioning thyroid nodules (AFTN). Radiofrequency ablation (RFA) is a minimally invasive procedure that has been proposed as an alternative treatment option for hyperthyroidism caused by AFTN. Although RFA has been shown to be useful for reducing nodule volume and improving TSH levels in AFTN, no comprehensive comparative clinical studies have been proposed to evaluate the overall response to RFA treatment. The aim of this comparative systematic review and meta-analysis was to evaluate the response of RAI and RFA treatments in AFTN.

Methods

A systematic search strategy was applied in PubMed, Web of Science, Scopus, Cochrane Library, and ClinicalTrials.gov until July 2023 without time or language restrictions. Studies investigating the response to RAI and/or RFA treatment in AFTN patients 6 and/or 12 months after treatment were included. The risk of bias was assessed based on the study design. Random-effect models were used for the meta-analysis.

Results

Twenty-three articles (28 reports) met the inclusion criteria and were included in the study. Overall, RAI therapy was found to have a significantly higher treatment response (94%) than RFA (59%), although the volume of AFTNs was reduced to a similar extent. In the direct comparison (n = 3 studies), RFA showed a higher risk of non-response than RAI (RR, 1.24; 95% CI, 0.94–1.63; z = 1.55; p = 0.12).

Conclusions

Our results demonstrate the superiority of RAI over RFA in terms of success rates and safety profile and confirm RAI as the first choice for the treatment of AFTNs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Hegedüs L. Clinical practice. The thyroid nodule. N Engl J Med [Internet]. 2004 [cited 2021 Dec 14];351:1764–71. Available from: https://pubmed.ncbi.nlm.nih.gov/15496625/.

  2. Corvilain B. The natural history of thyroid autonomy and hot nodules. Ann Endocrinol (Paris) [Internet]. 2003 [cited 2021 Dec 13];64:17–22. Available from: https://pubmed.ncbi.nlm.nih.gov/12707627/.

  3. Carlé A, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Rasmussen LB, et al. Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study. Eur J Endocrinol [Internet]. 2011 [cited 2023 Nov 17];164:801–9. Available from: https://pubmed.ncbi.nlm.nih.gov/21357288/.

  4. Giovanella L, Avram A, Clerc J. Molecular imaging for thyrotoxicosis and thyroid nodules. Journal of Nuclear Medicine [Internet]. 2021 [cited 2021 Nov 20];62:20S-25S. Available from: https://pubmed.ncbi.nlm.nih.gov/34230069/.

  5. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid [Internet]. 2016 [cited 2022 Feb 16];26:1–133. Available from: https://pubmed.ncbi.nlm.nih.gov/26462967/.

  6. Cho SJ, Baek JH, Chung SR, Choi YJ, Lee JH. L ong-term results of thermal ablation of benign thyroid nodules: a systematic review and meta-analysis. Endocrinol Metab (Seoul) [Internet]. 2020 [cited 2023 Nov 17];35:339–50. Available from: https://pubmed.ncbi.nlm.nih.gov/32615718/.

  7. Kim H, Cho S, Baek J, et al. Efficacy and safety of thermal ablation for autonomously functioning thyroid nodules: a systematic review and meta-analysis. Eur Radiol. 2021;31:605–15. https://pubmed.ncbi.nlm.nih.gov/32816198/.

    Article  PubMed  Google Scholar 

  8. Mauri G, Papini E, Bernardi S, et al. Image-guided thermal ablation in autonomously functioning thyroid nodules. A retrospective multicenter three-year follow-up study from the Italian Minimally Invasive Treatment of the Thyroid (MITT) Group. Eur Radiol. 2021;32:1738–46. https://pubmed.ncbi.nlm.nih.gov/34751793/.

    Article  PubMed  Google Scholar 

  9. Aktaş GE, Turoğlu HT, Erdil TY, İnanır S, Dede F. Long-term results of fixed high-dose I-131 treatment for toxic nodular goiter: higher euthyroidism rates in geriatric patients. Mol Imaging Radionucl Ther [Internet]. 2015 [cited 2023 Nov 17];24:94–9. Available from: https://pubmed.ncbi.nlm.nih.gov/27529883/.

  10. Cervelli R, Mazzeo S, Boni G, et al. Comparison between radioiodine therapy and single-session radiofrequency ablation of autonomously functioning thyroid nodules: a retrospective study. Clin Endocrinol (Oxf). 2019;90:608–16. https://pubmed.ncbi.nlm.nih.gov/30657603/.

    Article  CAS  PubMed  Google Scholar 

  11. Demir BK, Karakilic E, Saygili ES, Araci N, Ozdemir S. Predictors of hypothyroidism following empirical dose radioiodine in toxic thyroid nodules: real-life experience. Endocrine practice [Internet]. 2022 [cited 2023 Nov 17];28:749–53. Available from: https://pubmed.ncbi.nlm.nih.gov/35537668/.

  12. Døssing H, Bennedbæk FN, Bonnema SJ, Grupe P, Hegedüs L. Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules. Eur J Endocrinol [Internet]. 2007 [cited 2023 Nov 17];157:95–100. Available from: https://pubmed.ncbi.nlm.nih.gov/17609407/.

  13. Erdoğan MF, Küçük NÖ, Anl C, Aras S, Özer D, Aras G, et al. Effect of radioiodine therapy on thyroid nodule size and function in patients with toxic adenomas. Nucl Med Commun [Internet]. 2004 [cited 2023 Nov 17];25:1083–7. Available from: https://pubmed.ncbi.nlm.nih.gov/15577585/.

  14. Erkan ME, Demirin H, Aşik M, Celbek G, Yildirim M, Aydin Y, et al. Efficiency of radioactive I-131 therapy in geriatric patients with toxic nodular goiter. Aging Clin Exp Res [Internet]. 2012 [cited 2023 Nov 17];24:714–7. Available from: https://pubmed.ncbi.nlm.nih.gov/23211880/.

  15. Erturk M, Cekic B, Celik M, Demiray UI. Microwave ablation of autonomously functioning thyroid nodules: a comparative study with radioactive iodine therapy on the functional treatment success. Endokrynol Pol. 2021;72:120–5. https://pubmed.ncbi.nlm.nih.gov/33619707/.

    Article  CAS  PubMed  Google Scholar 

  16. Franklyn JA, Daykin J, Holder R, Sheppard MC. Radioiodine therapy compared in patients with toxic nodular or Graves’ hyperthyroidism. QJM [Internet]. 1995 [cited 2023 Nov 17];88:175–80. Available from: https://pubmed.ncbi.nlm.nih.gov/7767667/.

  17. Pereira L, Riguetto C, Neto A, Tambascia M, Ramos C, Zantut-Wittmann D. Fixed 30 mCi (1110 MBq) 131I-iodine therapy in autonomously functioning nodules: single toxic nodule as a predictive factor of success. World J Nucl Med [Internet]. 2021 [cited 2023 Nov 17];20:349–54. Available from: https://pubmed.ncbi.nlm.nih.gov/35018149/.

  18. Ratcliffe GE, Cooke S, Fogelman I, Maisey MN. Radioiodine treatment of solitary functioning thyroid nodules. Br J Radiol [Internet]. 1986 [cited 2023 Nov 17];59:385–7. Available from: https://pubmed.ncbi.nlm.nih.gov/3697616/.

  19. Roque C, Santos FS, Pilli T, Dalmazio G, Castagna MG, Pacini F. Long-term effects of radioiodine in toxic multinodular goiter: thyroid volume, function, and autoimmunity. J Clin Endocrinol Metab [Internet]. 2020 [cited 2023 Nov 17];105. Available from: https://pubmed.ncbi.nlm.nih.gov/32320467/.

  20. Şakı H, Cengiz A, Yürekli Y. Effectiveness of radioiodine treatment for toxic nodular goiter. Mol Imaging Radionucl Ther [Internet]. 2015 [cited 2023 Nov 17];24:100–4. Available from: https://pubmed.ncbi.nlm.nih.gov/27529884/.

  21. Sharma R, Bhatnagar A, Mondal A, Kashyap R, Khanna CM. Efficacy of standard ten millicurie dose of radio-iodine in management of autonomously functioning toxic thyroid nodules. J Assoc Physicians India [Internet]. 1995 [cited 2023 Nov 17];43:167–9, 172. Available from: https://pubmed.ncbi.nlm.nih.gov/11256900/.

  22. Ross DS, Ridgway EC, Daniels GH. Successful treatment of solitary toxic thyroid nodules with relatively low-dose iodine-131, with low prevalence of hypothyroidism. Ann Intern Med [Internet]. 1984 [cited 2023 Dec 4];101:488–90. Available from: https://pubmed.ncbi.nlm.nih.gov/6476634/.

  23. Barbaro D, Orsini P, Lapi P, Pasquini C, Tuco A, Righini A, et al. Percutaneous laser ablation in the treatment of toxic and pretoxic nodular goiter. Endocrine practice [Internet]. 2007 [cited 2023 Nov 17];13:30–6. Available from: https://pubmed.ncbi.nlm.nih.gov/17360298/.

  24. Bernardi S, Stacul F, Michelli A, et al. 12-month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules. Endocrine. 2017;57:402–8. https://pubmed.ncbi.nlm.nih.gov/27848197/.

    Article  CAS  PubMed  Google Scholar 

  25. Cesareo R, Naciu A, Iozzino M, et al. Nodule size as predictive factor of efficacy of radiofrequency ablation in treating autonomously functioning thyroid nodules. Int J Hyperthermia. 2018;34:617–23. https://pubmed.ncbi.nlm.nih.gov/29357717/.

    Article  CAS  PubMed  Google Scholar 

  26. Deandrea M, Limone P, Basso E, Mormile A, Ragazzoni F, Gamarra E, et al. US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med Biol [Internet]. 2008 [cited 2023 Nov 17];34:784–91. Available from: https://pubmed.ncbi.nlm.nih.gov/18207307/.

  27. Faggiano A, Ramundo V, Assanti AP, Fonderico F, Macchia PE, Misso C, et al. Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study. J Clin Endocrinol Metab [Internet]. 2012 [cited 2023 Nov 17];97:4439–45. Available from: https://pubmed.ncbi.nlm.nih.gov/23019349/.

  28. van der Meeren MMD, Joosten FBM, Roerink SHPP, Deden LN, Oyen WJG. Radiofrequency ablation for autonomously functioning nodules as treatment for hyperthyroidism: subgroup analysis of toxic adenoma and multinodular goitre and predictors for treatment success. Eur J Nucl Med Mol Imaging [Internet]. 2023 [cited 2023 Nov 17];50. Available from: https://pubmed.ncbi.nlm.nih.gov/37466647/.

  29. Cappelli C, Franco F, Pirola I, et al. Radiofrequency ablation of functioning and non-functioning thyroid nodules: a single institution 12-month survey. J Endocrinol Invest. 2020;43:477–82. https://pubmed.ncbi.nlm.nih.gov/31654311/.

    Article  CAS  PubMed  Google Scholar 

  30. Dobnig H, Amrein K. Monopolar radiofrequency ablation of thyroid nodules: a prospective austrian single-center study. Thyroid [Internet]. 2018 [cited 2023 Nov 17];28:472–80. Available from: /pmc/articles/PMC5905420/.

  31. Chianelli M, Bizzarri G, Todino V, Misischi I, Bianchini A, Graziano F, et al. Laser ablation and 131-iodine: a 24-month pilot study of combined treatment for large toxic nodular goiter. J Clin Endocrinol Metab [Internet]. 2014 [cited 2023 Nov 17];99. Available from: https://pubmed.ncbi.nlm.nih.gov/24684455/.

  32. Giovanella L, Piccardo A, Pezzoli C, Bini F, Ricci R, Ruberto T, et al. Comparison of high intensity focused ultrasound and radioiodine for treating toxic thyroid nodules. Clin Endocrinol (Oxf) [Internet]. 2018 [cited 2023 Nov 17];89:219–25. Available from: https://pubmed.ncbi.nlm.nih.gov/29741290/.

  33. Zingrillo M, Torlontano M, Ghiggi MR, Frusciante V, Varraso A, Liuzzi A, et al. Radioiodine and percutaneous ethanol injection in the treatment of large toxic thyroid nodule: a long-term study. Thyroid [Internet]. 2000 [cited 2023 Nov 17];10:985–9. Available from: https://pubmed.ncbi.nlm.nih.gov/11128727/.

  34. Sung J, Baek J, Jung S, et al. Radiofrequency ablation for autonomously functioning thyroid nodules: a multicenter study. Thyroid. 2015;25:112–7. https://pubmed.ncbi.nlm.nih.gov/25320840/.

    Article  CAS  PubMed  Google Scholar 

  35. Petranović Ovčariček P, Verburg FA, Hoffmann M, Iakovou I, Mihailovic J, Vrachimis A, et al. Higher thyroid hormone levels and cancer. Eur J Nucl Med Mol Imaging [Internet]. 2021 [cited 2022 Jun 7];48:808–21. Available from: https://pubmed.ncbi.nlm.nih.gov/32944783/.

  36. Hellevik AI, Asvold BO, Bjøro T, Romundstad PR, Nilsen TIL, Vatten LJ. Thyroid function and cancer risk: a prospective population study. Cancer Epidemiol Biomarkers Prev [Internet]. 2009 [cited 2016 Feb 19];18:570–4. Available from: http://cebp.aacrjournals.org/content/18/2/570.abstract.

  37. Khan SR, Chaker L, Ruiter R, Aerts JGJ V, Hofman A, Dehghan A, et al. Thyroid function and cancer risk: the Rotterdam study. J Clin Endocrinol Metab [Internet]. 2016 [cited 2020 Apr 7];101:5030–6. Available from: https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2016-2104.

Download references

Author information

Authors and Affiliations

Authors

Contributions

The study was conceived and designed by Luca Giovanella. Material preparation and data collection were performed by all authors. Data analysis was performed by Maria Luisa Garo. The first draft of the manuscript was written by Luca Giovanella and Maria Luisa Garo and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Luca Giovanella.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Giovanella, L., Garo, M.L., Campenní, A. et al. Radioiodine versus radiofrequency ablation to treat autonomously functioning thyroid nodules: a systematic review and comparative meta-analysis. Eur J Nucl Med Mol Imaging (2024). https://doi.org/10.1007/s00259-024-06625-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00259-024-06625-w

Keywords

Navigation